web analytics
1.2 C
Munich
Friday, December 2, 2022

TAG

CYDY

CytoDyn Inc (OTCMKTS: CYDY) On Watch as Company Hires Ambitious New CEO Who Charts Path Forward (Update on leronlimab)

CytoDyn Inc (OTCMKTS: CYDY) has formed a solid base over $0.30 and is beginning to move northbound again. The stock recently made a solid...

CytoDyn Inc (OTCMKTS: CYDY) Under Accumulation as New President Determines Path Forward for leronlimab

CytoDyn Inc (OTCMKTS: CYDY) has been on the rise since a brief dip below $0.50 following the recent runup from $0.231 to a high...

CytoDyn Inc (OTCMKTS: CYDY) Breaking Out Northbound as Biotech Hires New President, Raises $21.8 million & Sets Shareholders Meeting for August 31

CytoDyn Inc (OTCMKTS: CYDY) continues to move steadily higher in recent trading since hitting lows of $0.231 after the FDA placed a partial clinical...

CytoDyn Inc (OTCMKTS: CYDY) On the Comeback Trail (HIV Leronlimab Update)

CytoDyn Inc (OTCMKTS: CYDY) continues to move steadily higher in recent trading since hitting lows of $0.231 after the FDA placed a partial clinical...

CytoDyn Inc (OTCMKTS: CYDY) Major Reversal Brewing after Biotech Looks for Positive Outcome of Clinical Hold on HIV program

CytoDyn Inc (OTCMKTS: CYDY) is moving northbound after another test of $0.23 lows. The stock was one of the biggest runners of 2020 skyrocketing...

Todos Medical (TOMDF) & CYDY are Two Biotech Plays to Watch Monday After the Merck Expose

Todos Medical (OTCMKTS: TOMDF) and CytoDyn Inc. (OTCMKTS: CYDY) might be looking at a pretty good week ahead of them.  in a recent article...

Latest news